Statistics

Total Visits

Views
Cost-effectiveness analysis of telaprevir triple therapy for treatment-naive patients with chronic hepatitis C based on the combined efficacy data of the ADVANCE and OPTIMIZE studies59

Select a period of time:

Number of views in the range

Views
Cost-effectiveness analysis of telaprevir triple therapy for treatment-naive patients with chronic hepatitis C based on the combined efficacy data of the ADVANCE and OPTIMIZE studies8

Views

Views
August 20250
September 20251
October 20252
November 20253
December 20250
January 20262
February 20260
Download CSV file
 untranslated
 untranslated

Top country views

Views
Brazil3
United States2
Argentina1
Colombia1
Czech Republic1
 

Top cities views

Views
Curitiba1
Feira de Santana1
Porto Alegre1
Prague1
San Juan1